3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
11
Lung Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Carcinoma, Intraductal, Noninfiltrating
4
Breast Carcinoma In Situ
4
Brain Neoplasms
4
Unspecified Adult Solid Tumor, Protocol Specific
3
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Liver Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Hepatocellular
3
Salivary Gland Neoplasms
2
Precancerous Conditions
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Gliosarcoma
2
Glioblastoma
2
Esophageal Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma, Renal Cell
2
Adenocarcinoma Of Esophagus
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Interventions
Cisplatin
86
Radiotherapy
71
Paclitaxel
50
Fluorouracil
38
Carboplatin
36
Drug Therapy
32
Neoadjuvant Therapy
23
toripalimab
19
tislelizumab
18
pembrolizumab
17
camrelizumab
17
Irinotecan
17
Esophagectomy
17
Surgical Procedures, Operative
16
Radiation
16
Docetaxel
16
sintilimab
15
Oxaliplatin
14
130-nm albumin-bound paclitaxel
14
nimotuzumab
11
TP protocol
11
S 1 (combination)
11
Radiotherapy, Intensity-Modulated
11
Cetuximab
11
Capecitabine
11
Albumin-Bound Paclitaxel
10
apatinib
9
Leucovorin
9
Immune Checkpoint Inhibitors
8
nedaplatin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Esophageal Squamous Cell Carcinoma
×
Mass Spectrometry
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled